The disease of 1,000 faces, as MS is also known due to the variety of its symptoms, is one of the most common neurological diseases in young adulthood. It is still incurable. It is therefore all the more important to get to the bottom of the causes and development of the disease. Furthermore, diagnostic and therapeutic approaches must be further developed. The networked research in the disease-related Multiple Sclerosis Competence Network (KKNMS) offers the best conditions for this, as the Germany-wide cooperation of leading MS experts bundles expertise that is also visible internationally.
Research
KKNMS core projects on multiple sclerosis
Research
Use samples and data from the KKNMS for your own research projects
Research
Latest research results with the participation of the KKNMS
What is multiple sclerosis?
About MS | MS Brain Bank | Patient Handbook | DMSG
Find out the cause and origin –
develop new therapies
During the period of BMBF funding (until 2019), the KKNMS set different priorities in five consortia in order to get to the bottom of multiple sclerosis: Infrastructure, Cohorts and Trials, Prognostic and Treatment markers, Determinants of MS phenotypes and Modeling.
Essentially, the following core objectives were targeted:
- Better understanding of the development of MS through close exchange between basic and clinical research. The aim is to develop specific MS therapies on this basis.
- Identification of biomarkers that simplify the diagnosis and differential diagnosis of MS and make it easier to predict the course of the disease. The aim is to achieve individualized therapy for MS patients on this basis
- Better understanding of the genetic correlations in the development and progression of MS. The aim is to identify and confirm genetic variants that have an influence on individual disease parameters.
- Improving research tools: developing new models that can be used to study the disease in the laboratory.